Filing Details
- Accession Number:
- 0000014272-20-000173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-26 17:17:04
- Reporting Period:
- 2020-05-22
- Accepted Time:
- 2020-05-26 17:17:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744507 | Adam Dubow | Bristol-Myers Squibb Company 430 E. 29Th Street, 14 Floor New York NY 10016 | Svp,Chiefcompliance&Ethicsoff. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2020-05-22 | 3,200 | $61.01 | 16,086 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 937 | Indirect | By BMY Savings and Investment Program |
Footnotes
- Based on a plan statement as of the end of the most recent fiscal quarter.